Keywords: Dainippon Sumitomo, Calsed, China, Small cell lung cancer, SFDA

Dainippon Sumitomo files for approval of Calsed in China

Article | 06 September 2012

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has submitted an imported drug registration application in China for anticancer antibiotic amrubicin ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Dainippon Sumitomo Pharma

Go to company listing

Related Drugs

Calsed

Go to drug listing